ID: ALA205128

Max Phase: Preclinical

Molecular Formula: C25H19N5O5

Molecular Weight: 469.46

Molecule Type: Small molecule

Representations

Canonical SMILES:  N#Cc1cccc(-c2cc(C(CC(=O)O)C(=O)O)cc(-c3nc4cc(C(=N)N)ccc4[nH]3)c2O)c1

Standard InChI:  InChI=1S/C25H19N5O5/c26-11-12-2-1-3-13(6-12)16-7-15(17(25(34)35)10-21(31)32)8-18(22(16)33)24-29-19-5-4-14(23(27)28)9-20(19)30-24/h1-9,17,33H,10H2,(H3,27,28)(H,29,30)(H,31,32)(H,34,35)

Standard InChI Key:  GGKPWIXGKBVTFC-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 469.46

Molecular Weight (Monoisotopic): 469.1386

AlogP: 3.40

#Rotatable Bonds: 7

Polar Surface Area: 197.17

Molecular Species: ZWITTERION

HBA: 6

HBD: 6

#RO5 Violations: 1

HBA (Lipinski): 10

HBD (Lipinski): 7

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 3.27

CX Basic pKa: 10.60

CX LogP: 0.65

CX LogD: -1.54

Aromatic Rings: 4

Heavy Atoms: 35

QED Weighted: 0.17

Np Likeness Score: -0.44

References

1. Shrader WD, Kolesnikov A, Burgess-Henry J, Rai R, Hendrix J, Hu H, Torkelson S, Ton T, Young WB, Katz BA, Yu C, Tang J, Cabuslay R, Sanford E, Janc JW, Sprengeler PA..  (2006)  Factor VIIa inhibitors: gaining selectivity within the trypsin family.,  16  (6): [PMID:16413783] [10.1016/j.bmcl.2005.12.040]

2. Young WB, Rai R, Shrader WD, Burgess-Henry J, Hu H, Elrod KC, Sprengeler PA, Katz BA, Sukbuntherng J, Mordenti J..  (2006)  Small molecule inhibitors of plasma kallikrein.,  16  (7): [PMID:16413183] [10.1016/j.bmcl.2005.12.060]

Source

Source(1):

• Scientific Literature